Plain-English translation of NCT07228611 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
After a stroke, your bones may become weaker — a condition called osteoporosis — but doctors don't yet know exactly who is at highest risk or when this happens. This study will measure bone density in people who have had a stroke at different stages of recovery and compare them to healthy volunteers. By identifying which patients are most at risk, researchers hope to help doctors catch bone loss early and prevent fractures.
Stroke survivors often become less active, which can weaken bones over time. However, doctors need better tools to predict who will develop serious bone loss and when to start treatment. This study will help identify warning signs so that at-risk patients can get help before fractures occur.
You likely qualify if…
You likely don't qualify if…
You will visit the research center for bone density scans (similar to an X-ray) and health assessments. The study compares three groups: people in early stroke recovery (1 week to 6 months), people in long-term recovery (over 1 year), and healthy volunteers without stroke history. There are no medications to take — the study simply measures your bone health and collects information about factors that might affect your bones.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Ankara Etlik City Hospital
Enrollment target
~84 participants
Started
December 2025
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
55 Years – 85 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ayşe Naz Kalem Özgen, specialist
Ankara Etlik City Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.